Intensive versus standard blood pressure control in patients with and without type 2 diabetes: A systematic review and meta-analysis
Medicina Clínica · 2026
DOI: 10.1016/j.medcli.2025.107318 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Medicina Clínica, 2026. Verfasst von João Victor de Oliveira Ramos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Sciences Center, Federal University of Paraíba, João Pessoa, Brazil. Electronic address: ramosjoaovictor9713@gmail.com. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypertension, Antihypertensive Agents. Die Arbeit nennt 48 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND: The optimal intensity of blood pressure (BP) control in patients with and without type 2 diabetes mellitus (T2D) remains unclear. OBJECTIVES: We performed a systematic review and meta-analysis of randomized controlled trials comparing intensive versus standard BP control, stratified by T2D status. METHODS: Primary outcomes were all-cause mortality and serious adverse events (SAEs); secondary outcomes included death from cardiovascular causes and occurrence of myocardial infarction (MI) and stroke. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using DerSimonian-Laird random-effects models. Heterogeneity was assessed with the I2 statistic, and leave-one-out sensitivity analyses were conducted for all outcomes. RESULTS: Six trials comprising 41,210 participants were included. Intensive BP control significantly reduced death from cardiovascular causes (OR 0.72; 95% CI 0.56-0.93), incidence of MI (OR 0.85; 95% CI 0.74-0.97), and stroke (OR 0.78; 95% CI 0.68-0.89). The reduction in all-cause mortality was significant in patients without T2D (OR 0.73; 95% CI 0.59-0.90), but not in those with T2D (OR 0.99; 95% CI 0.85-1.14). Intensive control was associated with a non-significant increase in SAEs overall (OR 1.15; 95% CI 0.90-1.46), with higher estimates in patients with T2D. CONCLUSIONS: Intensive BP control reduces cardiovascular events and mortality in non-diabetic patients. In those with T2D, benefits are attenuated and may be counterbalanced by safety concerns. BP targets should be individualized based on diabetes status and clinical context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Sciences Center, Federal University of Paraíba, João Pessoa, Brazil. Electronic address: ramosjoaovictor9713@gmail.com.
- Medical Sciences Center, Federal University of Paraíba, João Pessoa, Brazil.
- Lauro Wanderley University Hospital, Department of Internal Medicine, Federal University of Paraíba, João Pessoa, Brazil.
Zitieren
APA
de Oliveira Ramos, J. V., Andrade Fernandes, J. V., Camilo Madruga de Oliveira Lima, F. M., Toscano Matias, J. L., de Lima Beltrão, F. E., & Tavares de Melo, M. D. (2026). Intensive versus standard blood pressure control in patients with and without type 2 diabetes: A systematic review and meta-analysis. Medicina Clínica. https://doi.org/10.1016/j.medcli.2025.107318
Vancouver
de Oliveira Ramos JV, Andrade Fernandes JV, Camilo Madruga de Oliveira Lima FM, Toscano Matias JL, de Lima Beltrão FE, Tavares de Melo MD. Intensive versus standard blood pressure control in patients with and without type 2 diabetes: A systematic review and meta-analysis. Medicina Clínica. 2026. doi:10.1016/j.medcli.2025.107318
BibTeX
@article{deOliveiraRamos2026,
author = {de Oliveira Ramos, João Victor and Andrade Fernandes, João Vitor and Camilo Madruga de Oliveira Lima, Flávia Maria and Toscano Matias, José Lucas and de Lima Beltrão, Fabyan Esberard and Tavares de Melo, Marcelo Dantas},
title = {Intensive versus standard blood pressure control in patients with and without type 2 diabetes: A systematic review and meta-analysis},
journal = {Medicina Clínica},
year = {2026},
doi = {10.1016/j.medcli.2025.107318}
}
EUVIMED